Spleen‐targeted neoantigen DNA vaccine for personalized immunotherapy of hepatocellular carcinoma

Neoantigens are emerging as attractive targets to develop personalized cancer vaccines, but their immunization efficacy is severely hampered by their restricted accessibility to lymphoid tissues where immune responses are initiated. Leveraging the capability of red blood cells (RBCs) to capture and...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Ming, Luo, Zijin, Cai, Zhixiong, Mao, Qianqian, Li, Zhenli, Li, Hao, Zhang, Cao, Zhang, Yuting, Zhong, Aoxue, Wu, Liming, Liu, Xiaolong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10565630/
https://www.ncbi.nlm.nih.gov/pubmed/37552209
http://dx.doi.org/10.15252/emmm.202216836

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10565630/
https://www.ncbi.nlm.nih.gov/pubmed/37552209
http://dx.doi.org/10.15252/emmm.202216836

Ejemplares similares